Literature DB >> 22124756

Chronic exercise modulates RAS components and improves balance between pro- and anti-inflammatory cytokines in the brain of SHR.

Deepmala Agarwal1, Michael A Welsch, Jeffrey N Keller, Joseph Francis.   

Abstract

Recently, exercise has been recommended as a part of lifestyle modification for all hypertensive patients; however, the precise mechanisms of its effects on hypertension are largely unknown. Therefore, this study aimed to investigate the mechanisms within the brain that can influence exercise-induced effects in an animal model of human essential hypertension. Young normotensive WKY rats and SHR were given moderate-intensity exercise for 16 weeks. Blood pressure was measured bi-weekly by tail-cuff method. Animals were then euthanized; paraventricular nucleus (PVN) and rostral ventrolateral medulla (RVLM), important cardiovascular regulatory centers in the brain, were collected and analyzed by real-time RT-PCR, Western blot, EIA, and fluorescent microscopy. Exercise of 16-week duration attenuated systolic, diastolic, and mean arterial pressure in SHR. Sedentary SHR exhibited increased pro-inflammatory cytokines (PICs) and decreased anti-inflammatory IL-10 levels in the PVN and RVLM. Furthermore, SHR(sed) rats exhibited elevated levels of ACE, AT1R, and decreased levels of ACE2 and receptor Mas in the PVN and RVLM. Chronic exercise not only prevented the increase in PICs (TNF-α, IL-1β), ACE, and AT1R protein expression in the brain of SHR, but also dramatically upregulated IL-10, ACE2, and Mas receptor expression in SHR. In addition, these changes were associated with reduced plasma AngII levels, reduced neuronal activity, reduced NADPH-oxidase subunit gp91(phox) and inducible NO synthase in trained SHRs indicating reduced oxidative stress. These results suggest that chronic exercise not only attenuates PICs and the vasoconstrictor axis of the RAS but also improves the anti-inflammatory defense mechanisms and vasoprotective axis of the RAS in the brain, which, at least in part, explains the blood pressure-lowering effects of exercise in hypertension.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22124756      PMCID: PMC3261080          DOI: 10.1007/s00395-011-0231-7

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  66 in total

1.  ACE2 overexpression in the paraventricular nucleus attenuates angiotensin II-induced hypertension.

Authors:  Srinivas Sriramula; Jeffrey P Cardinale; Eric Lazartigues; Joseph Francis
Journal:  Cardiovasc Res       Date:  2011-09-27       Impact factor: 10.787

2.  Heart disease and stroke statistics--2010 update: a report from the American Heart Association.

Authors:  Donald Lloyd-Jones; Robert J Adams; Todd M Brown; Mercedes Carnethon; Shifan Dai; Giovanni De Simone; T Bruce Ferguson; Earl Ford; Karen Furie; Cathleen Gillespie; Alan Go; Kurt Greenlund; Nancy Haase; Susan Hailpern; P Michael Ho; Virginia Howard; Brett Kissela; Steven Kittner; Daniel Lackland; Lynda Lisabeth; Ariane Marelli; Mary M McDermott; James Meigs; Dariush Mozaffarian; Michael Mussolino; Graham Nichol; Véronique L Roger; Wayne Rosamond; Ralph Sacco; Paul Sorlie; Véronique L Roger; Randall Stafford; Thomas Thom; Sylvia Wasserthiel-Smoller; Nathan D Wong; Judith Wylie-Rosett
Journal:  Circulation       Date:  2009-12-17       Impact factor: 29.690

3.  Angiotensin II receptor 1 involved in the central pressor response induced by interleukin-1 beta in the paraventricular nucleus.

Authors:  Yang Lu; Jianguang Chen; Xiaohua Yin; Hua Zhao
Journal:  Neurol Res       Date:  2008-11-26       Impact factor: 2.448

4.  Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system.

Authors:  Matthew C Zimmerman; Eric Lazartigues; Ram V Sharma; Robin L Davisson
Journal:  Circ Res       Date:  2004-06-10       Impact factor: 17.367

5.  Brain tumour necrosis factor-alpha modulates neurotransmitters in hypothalamic paraventricular nucleus in heart failure.

Authors:  Yu-Ming Kang; Rong-Li He; Li-Min Yang; Da-Nian Qin; Anuradha Guggilam; Carrie Elks; Ning Yan; Zheng Guo; Joseph Francis
Journal:  Cardiovasc Res       Date:  2009-05-20       Impact factor: 10.787

6.  Role of proinflammatory cytokines and redox homeostasis in exercise-induced delayed progression of hypertension in spontaneously hypertensive rats.

Authors:  Deepmala Agarwal; Masudul Haque; Srinivas Sriramula; Nithya Mariappan; Romain Pariaut; Joseph Francis
Journal:  Hypertension       Date:  2009-10-19       Impact factor: 10.190

7.  Exercise training improves aortic endothelium-dependent vasorelaxation and determinants of nitric oxide bioavailability in spontaneously hypertensive rats.

Authors:  Drew A Graham; James W E Rush
Journal:  J Appl Physiol (1985)       Date:  2004-01-29

8.  Tempol attenuates excitatory actions of angiotensin II in the rostral ventrolateral medulla during emotional stress.

Authors:  Dmitry N Mayorov; Geoffrey A Head; Robert De Matteo
Journal:  Hypertension       Date:  2004-05-24       Impact factor: 10.190

Review 9.  Is the brain the essential in hypertension?

Authors:  J Richard Jennings; Ydwine Zanstra
Journal:  Neuroimage       Date:  2009-05-04       Impact factor: 6.556

Review 10.  NADPH oxidases in cardiovascular disease: insights from in vivo models and clinical studies.

Authors:  Alexander Sirker; Min Zhang; Ajay M Shah
Journal:  Basic Res Cardiol       Date:  2011-05-20       Impact factor: 17.165

View more
  57 in total

1.  Short hairpin RNA interference targeting interleukin 1 receptor type I in the paraventricular nucleus attenuates hypertension in rats.

Authors:  Peng Lu; Shu-Jun Jiang; Hong Pan; Ai-Li Xu; Gui-Hua Wang; Chun-Lei Ma; Zhen Shi
Journal:  Pflugers Arch       Date:  2017-11-16       Impact factor: 3.657

Review 2.  The relationship of stress and blood pressure effectors.

Authors:  C Ayada; Ü Toru; Y Korkut
Journal:  Hippokratia       Date:  2015 Apr-Jun       Impact factor: 0.471

Review 3.  Modulation of angiotensin II signaling following exercise training in heart failure.

Authors:  Irving H Zucker; Harold D Schultz; Kaushik P Patel; Hanjun Wang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-02-13       Impact factor: 4.733

4.  Chronic estrogen exposure affects gene expression in the rostral ventrolateral medulla of young and aging rats: Possible role in hypertension.

Authors:  Madhan Subramanian; Coral Hahn-Townsend; Kimberly A Clark; Sheba M J MohanKumar; P S MohanKumar
Journal:  Brain Res       Date:  2015-09-12       Impact factor: 3.252

5.  MicroRNA network changes in the brain stem underlie the development of hypertension.

Authors:  Danielle DeCicco; Haisun Zhu; Anthony Brureau; James S Schwaber; Rajanikanth Vadigepalli
Journal:  Physiol Genomics       Date:  2015-06-30       Impact factor: 3.107

6.  Chronic exercise normalizes changes in Cav 1.2 and KCa 1.1 channels in mesenteric arteries from spontaneously hypertensive rats.

Authors:  Lijun Shi; Hanmeng Zhang; Yu Chen; Yujia Liu; Ni Lu; Tengteng Zhao; Lubo Zhang
Journal:  Br J Pharmacol       Date:  2015-01-23       Impact factor: 8.739

Review 7.  Neural Control of Non-vasomotor Organs in Hypertension.

Authors:  Chansol Hurr; Colin N Young
Journal:  Curr Hypertens Rep       Date:  2016-04       Impact factor: 5.369

Review 8.  Neuroimmune communication in hypertension and obesity: a new therapeutic angle?

Authors:  Annette D de Kloet; Eric G Krause; Peng D Shi; Jasenka Zubcevic; Mohan K Raizada; Colin Sumners
Journal:  Pharmacol Ther       Date:  2013-02-28       Impact factor: 12.310

9.  Angiotensin II regulates ACE and ACE2 in neurons through p38 mitogen-activated protein kinase and extracellular signal-regulated kinase 1/2 signaling.

Authors:  Liang Xiao; Karla K V Haack; Irving H Zucker
Journal:  Am J Physiol Cell Physiol       Date:  2013-03-27       Impact factor: 4.249

Review 10.  Opposing tissue-specific roles of angiotensin in the pathogenesis of obesity, and implications for obesity-related hypertension.

Authors:  Nicole K Littlejohn; Justin L Grobe
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-10-21       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.